Veerhealth Care Statistics
Total Valuation
Veerhealth Care has a market cap or net worth of INR 358.97 million. The enterprise value is 403.12 million.
| Market Cap | 358.97M |
| Enterprise Value | 403.12M |
Important Dates
The next estimated earnings date is Tuesday, February 10, 2026.
| Earnings Date | Feb 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Veerhealth Care has 20.00 million shares outstanding. The number of shares has increased by 0.27% in one year.
| Current Share Class | 20.00M |
| Shares Outstanding | 20.00M |
| Shares Change (YoY) | +0.27% |
| Shares Change (QoQ) | -3.24% |
| Owned by Insiders (%) | 43.93% |
| Owned by Institutions (%) | 2.81% |
| Float | 11.10M |
Valuation Ratios
The trailing PE ratio is 76.79.
| PE Ratio | 76.79 |
| Forward PE | n/a |
| PS Ratio | 1.91 |
| PB Ratio | 1.58 |
| P/TBV Ratio | 1.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 29.35, with an EV/FCF ratio of -3.93.
| EV / Earnings | 86.88 |
| EV / Sales | 2.14 |
| EV / EBITDA | 29.35 |
| EV / EBIT | 152.41 |
| EV / FCF | -3.93 |
Financial Position
The company has a current ratio of 2.26, with a Debt / Equity ratio of 0.20.
| Current Ratio | 2.26 |
| Quick Ratio | 0.65 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | 3.30 |
| Debt / FCF | -0.44 |
| Interest Coverage | 1.46 |
Financial Efficiency
Return on equity (ROE) is 2.06% and return on invested capital (ROIC) is 0.89%.
| Return on Equity (ROE) | 2.06% |
| Return on Assets (ROA) | 0.51% |
| Return on Invested Capital (ROIC) | 0.89% |
| Return on Capital Employed (ROCE) | 0.85% |
| Weighted Average Cost of Capital (WACC) | 6.07% |
| Revenue Per Employee | 4.70M |
| Profits Per Employee | 116,000 |
| Employee Count | 40 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 4.62 |
Taxes
In the past 12 months, Veerhealth Care has paid 564,000 in taxes.
| Income Tax | 564,000 |
| Effective Tax Rate | 10.84% |
Stock Price Statistics
The stock price has decreased by -10.83% in the last 52 weeks. The beta is 0.39, so Veerhealth Care's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | -10.83% |
| 50-Day Moving Average | 18.42 |
| 200-Day Moving Average | 18.03 |
| Relative Strength Index (RSI) | 45.15 |
| Average Volume (20 Days) | 41,822 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Veerhealth Care had revenue of INR 188.11 million and earned 4.64 million in profits. Earnings per share was 0.23.
| Revenue | 188.11M |
| Gross Profit | 58.98M |
| Operating Income | 2.65M |
| Pretax Income | 5.20M |
| Net Income | 4.64M |
| EBITDA | 13.73M |
| EBIT | 2.65M |
| Earnings Per Share (EPS) | 0.23 |
Balance Sheet
The company has 1.22 million in cash and 45.36 million in debt, with a net cash position of -44.14 million or -2.21 per share.
| Cash & Cash Equivalents | 1.22M |
| Total Debt | 45.36M |
| Net Cash | -44.14M |
| Net Cash Per Share | -2.21 |
| Equity (Book Value) | 227.12M |
| Book Value Per Share | 11.71 |
| Working Capital | 38.80M |
Cash Flow
In the last 12 months, operating cash flow was -7.34 million and capital expenditures -95.26 million, giving a free cash flow of -102.60 million.
| Operating Cash Flow | -7.34M |
| Capital Expenditures | -95.26M |
| Free Cash Flow | -102.60M |
| FCF Per Share | -5.13 |
Margins
Gross margin is 31.35%, with operating and profit margins of 1.41% and 2.47%.
| Gross Margin | 31.35% |
| Operating Margin | 1.41% |
| Pretax Margin | 2.77% |
| Profit Margin | 2.47% |
| EBITDA Margin | 7.30% |
| EBIT Margin | 1.41% |
| FCF Margin | n/a |
Dividends & Yields
Veerhealth Care does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.27% |
| Shareholder Yield | -0.27% |
| Earnings Yield | 1.29% |
| FCF Yield | -28.58% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 22, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Sep 22, 2023 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |